Early cardiac events pose major and different risks in close relatives, finds study news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Charles H. Hennekens, M.D., Dr.PH. senior author, the First Sir Richard Doll Professor and senior academic advisor in FAU s Schmidt College of Medicine. view more
Credit: Alex Dolce, Florida Atlantic University
Family history of early cardiac events in first degree relatives such as a parent or sibling is a major risk factor, especially for premature events. Currently, data on risks in close relatives of patients with a family history of premature heart attacks, chronic stable angina or peripheral vascular disease are sparse.
Researchers from Florida Atlantic University s Schmidt College of Medicine in collaboration with an international team of leading scientists in Italy, the United Kingdom and Poland, assembled a consecutive series of 230 patients with premature onset of heart attacks, strokes, angina or peripheral artery disease and a comparison group of apparently healthy men and women during a 24-month period. The comparison group had no family
Early Cardiac Events Pose Major and Diverse Risks in Close Relatives
A study investigating a consecutive series of 230 patients with premature onset of heart attacks, strokes, angina or peripheral artery disease and a comparison group shows that family history of early onset cardiac events is a major and independent risk factor in close relatives.
Family history of early cardiac events in first degree relatives such as a parent or sibling is a major risk factor, especially for premature events. Currently, data on risks in close relatives of patients with a family history of premature heart attacks, chronic stable angina or peripheral vascular disease are sparse.
COVID is shaping the evolution of nursing homes, experts say newsday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsday.com Daily Mail and Mail on Sunday newspapers.
(Photo : user 41330 on Pixabay)
Even though established parasites inside the red blood cells are extinct, the fatality rate is due to ongoing cyto-adhesion to infected erythrocytes.
New avenues are desperately needed as malaria vaccines have shown to be less than moderately successful and to treat these serious cases of P. falciparum malaria.
The latest figures suggest that more than 500 million malaria cases and more than 400,000 deaths are recorded annually worldwide. The secret to dramatically enhancing survival rates could be anti-adhesion medications.
Medical Study
A first-of-its-kind study by Florida Atlantic University s Schmidt College of Medicine in conjunction with FAU s Charles E. Schmidt College of Science and the Division of Chemical Sciences, National Institute of Standards and Technology, United States Department of Commerce, indicates that these conotoxins could theoretically cure malaria using venom from the Conus nux, a species of sea snail.